| 000 | 01214 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516231814.0 | ||
| 264 | 0 | _c20150810 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/1381612820666140825125715 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLane, Deirdre A | |
| 245 | 0 | 0 |
_aBest practice for atrial fibrillation patient education. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2015 |
||
| 300 |
_a533-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 | _aHealth Knowledge, Attitudes, Practice |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 |
_aPatient Education as Topic _xstandards |
| 650 | 0 | 4 |
_aPractice Guidelines as Topic _xstandards |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStroke _xetiology |
| 700 | 1 | _aBarker, Rachel V | |
| 700 | 1 | _aLip, Gregory Y H | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 21 _gno. 5 _gp. 533-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612820666140825125715 _zAvailable from publisher's website |
| 999 |
_c24147099 _d24147099 |
||